Elaine Lee Hsia, DO
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · Valley Medical Group-Renton
Looking this up.
Hospitals listed: Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsia’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
State licence records
1 licence
- Washington DO.OP.61166424Osteopathic Physician & Surgeon License · since 2021 · expires 2026-10-20ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Valley Medical CenterRenton, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.69 (1.38 to 1.99), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 3.51 (2.89 to 4.13) · 5,445 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.4 (10.8 to 19) · 208 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.441, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.513, Oct 2024 – Sep 2025
See every measure and the patient survey for Valley Medical Center
Behind the star rating — Deaths: 1 better, 4 the same, 2 worse of 7 measures. Safety: 1 better, 4 the same, 1 worse of 6 measures. Readmissions: 2 better, 5 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.69 (1.38 to 1.99) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 3.51 (2.89 to 4.13) · 5,445 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.4 (10.8 to 19) · 208 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.441 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.513 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,237 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.11 (128.65 to 221.56) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 16.2 · 511 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.4 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 506 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,498 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.34) · 6,246 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.13 to 0.51) · 6,227 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (1.2 to 5.2) · 1,469 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.9 (0.27 to 3.53) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (1.17 to 4.12) · 1,452 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.56 (0 to 13.24) · 571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.55 (0 to 7.13) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 312 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.003 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.869 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.9 · 102 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.1 · 386 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 638 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (2.9 to 6.3) · 208 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 279 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.9 to 15.9) · 2,650 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 760 cases | No different | Jan 2024 – Dec 2024 |
What patients said (904 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$36,863
Medicare paid this office $36,863 for 134 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 91 | $13,550 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $9,277 | $143 |
| Short return visit (20+ min) | 60 | $5,012 | $68 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,477 | $267 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $998 | $12 |
See all 8 services
| Return visit (30+ min) | 91 | $13,550 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 65 | $9,277 | $143 |
| Short return visit (20+ min) | 60 | $5,012 | $68 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 13 | $3,477 | $267 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 48 | $998 | $12 |
| Influenza vaccine split virus, preservative free | 16 | $659 | $41 |
| Administration of influenza virus vaccine | 18 | $641 | $36 |
| Administration of pneumococcal vaccine | 12 | $427 | $36 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
134 Original Medicare patients in 2024. Average age 73 · Women 62% · Also on Medicaid 15% · Health risk score 1.01. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 58% · Diabetes 25% · Chronic kidney disease 17% · Cancer 13% · Depression 13% · COPD 9% · Atrial fibrillation 9% · Dementia 9% · Coronary heart disease 8%.
The office billed $97,755, Medicare allowed $48,005 and paid $36,863; for 485 services of 33 kinds; $4,223 of it was for drugs given in the office and $32,640 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 134 | 485 | 73 | 1.01 | $97,755 | $36,863 |
| 2023 | 154 | 345 | 74 | 1.02 | $79,333 | $22,872 |
| 2022 | 182 | 459 | 74 | 1.10 | $86,280 | $30,708 |
| 2021 | 67 | 131 | 73 | 0.99 | $23,450 | $9,943 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 92 | $8,068 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 39 | $5,027 | $129 |
| Short return visit (20+ min) | 59 | $3,939 | $53 |
| New patient visit (45+ min) | 11 | $561 | $51 |
| Urinalysis, manual test | 11 | $38 | $3 |
2022: 6 services
| Return visit (30+ min) | 79 | $10,597 | $86 |
| Short return visit (20+ min) | 105 | $8,531 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,183 | $144 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 19 | $1,299 | $68 |
| Administration of influenza virus vaccine | 21 | $702 | $33 |
| Urinalysis, manual test | 19 | $86 | $3 |
2021: 4 services
| Return visit (30+ min) | 27 | $3,136 | $108 |
| Short return visit (20+ min) | 26 | $1,847 | $71 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | $664 | $60 |
| Administration of influenza virus vaccine | 13 | $251 | $19 |
Medicaid work
$19,312 in 2024
Medicaid paid $19,312 for 402 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 276 | $13,788 |
| Short return visit (20+ min) | 126 | $5,524 |
| 2024 | 402 | 2 | 34 | $19,312 |
| 2023 | 450 | 2 | 40 | $23,662 |
| 2022 | 644 | 2 | 37 | $34,208 |
| 2021 | 61 | 2 | 17 | $3,585 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 281 | $15,693 |
| Short return visit (20+ min) | 169 | $7,969 |
2022
| Return visit (30+ min) | 298 | $18,087 |
| Short return visit (20+ min) | 346 | $16,121 |
2021
| Return visit (30+ min) | 49 | $2,997 |
| Short return visit (20+ min) | 12 | $589 |
Drugs they prescribed that Part D paid
$288,563
Pharmacies billed $288,563 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (87 of 4,565) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
4,155 generic and 363 brand-name prescriptions · $288,563 in drug cost · 67 antibiotic prescriptions to 50 people · 42 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 35 | $47,922 | $1,369 |
| Jardiance | 32 | $46,893 | $1,465 |
| Xarelto | 17 | $27,933 | $1,643 |
| Eliquis | 21 | $21,599 | $1,029 |
| Januvia | 21 | $20,512 | $977 |
See all 86 drugs
| Ozempic | 35 | $47,922 | $1,369 |
| Jardiance | 32 | $46,893 | $1,465 |
| Xarelto | 17 | $27,933 | $1,643 |
| Eliquis | 21 | $21,599 | $1,029 |
| Januvia | 21 | $20,512 | $977 |
| Qvar Redihaler | 11 | $4,270 | $388 |
| Atorvastatin | 444 | $2,968 | $7 |
| Lantus Solostar | 31 | $2,900 | $94 |
| Gabapentin | 127 | $2,220 | $17 |
| Amlodipine Besylate | 287 | $2,082 | $7 |
| Losartan | 209 | $1,900 | $9 |
| Albuterol Sulfate Hfa | 60 | $1,644 | $27 |
| Lisinopril | 224 | $1,555 | $7 |
| Levothyroxine | 146 | $1,304 | $9 |
| Omeprazole | 71 | $1,298 | $18 |
| Pantoprazole | 89 | $1,037 | $12 |
| Metoprolol | 87 | $1,036 | $12 |
| Tamsulosin | 58 | $962 | $17 |
| Hydroxyzine | 20 | $888 | $44 |
| Metformin | 113 | $884 | $8 |
| Pravastatin | 90 | $862 | $10 |
| Famotidine | 85 | $846 | $10 |
| Ultra-Fine Short Pen Needle | 13 | $835 | $64 |
| Allopurinol | 66 | $829 | $13 |
| Montelukast | 43 | $701 | $16 |
| Benazepril | 28 | $691 | $25 |
| Bupropion Xl | 25 | $646 | $26 |
| Duloxetine | 32 | $645 | $20 |
| Metformin Hcl Er | 101 | $639 | $6 |
| Clopidogrel | 42 | $625 | $15 |
| Oxybutynin Chloride | 16 | $580 | $36 |
| Telmisartan | 16 | $563 | $35 |
| Hydrocodone-Acetaminophen | 37 | $562 | $15 |
| Potassium Chloride | 27 | $547 | $20 |
| Diclofenac | 21 | $500 | $24 |
| Valacyclovir | 22 | $492 | $22 |
| Chlorthalidone | 19 | $475 | $25 |
| Synthroid | 11 | $471 | $43 |
| Rosuvastatin | 78 | $470 | $6 |
| Quetiapine | 32 | $458 | $14 |
| Azelastine | 15 | $426 | $28 |
| Fluticasone Propionate | 41 | $405 | $10 |
| Furosemide | 70 | $392 | $6 |
| Cyclobenzaprine | 17 | $375 | $22 |
| Simvastatin | 53 | $374 | $7 |
| Trazodone | 36 | $358 | $10 |
| Propranolol | 30 | $357 | $12 |
| Metoprolol | 27 | $355 | $13 |
| Venlafaxine Hcl Er | 23 | $349 | $15 |
| Acetaminophen-Codeine | 11 | $334 | $30 |
| Ondansetron Odt | 25 | $314 | $13 |
| Hydrochlorothiazide | 81 | $308 | $4 |
| Losartan-Hydrochlorothiazide | 27 | $306 | $11 |
| Glipizide | 34 | $284 | $8 |
| Citalopram Hbr | 20 | $260 | $13 |
| Glipizide Er | 11 | $259 | $24 |
| Alendronate | 50 | $252 | $5 |
| Escitalopram | 27 | $251 | $9 |
| Triamcinolone Acetonide | 26 | $246 | $9 |
| Glimepiride | 25 | $220 | $9 |
| Sertraline | 56 | $220 | $4 |
| Fluoxetine | 25 | $208 | $8 |
| Diltiazem 24hr Er (Cd) | 16 | $205 | $13 |
| Isosorbide Mononitrate Er | 13 | $197 | $15 |
| Baclofen | 18 | $189 | $10 |
| Ibuprofen | 27 | $187 | $7 |
| Donepezil | 13 | $174 | $13 |
| Olmesartan Medoxomil | 13 | $169 | $13 |
| Divalproex | 12 | $164 | $14 |
| Zolpidem | 11 | $154 | $14 |
| Triamterene-Hydrochlorothiazid | 21 | $135 | $6 |
| Meloxicam | 17 | $133 | $8 |
| Hydroxyzine Pamoate | 19 | $124 | $7 |
| Acyclovir | 11 | $115 | $10 |
| Lovastatin | 15 | $107 | $7 |
| Oxycodone | 13 | $94 | $7 |
| Atenolol | 22 | $78 | $4 |
| Amoxicillin-Clavulanate Potass | 14 | $69 | $5 |
| Lorazepam | 25 | $67 | $3 |
| Tramadol | 19 | $65 | $3 |
| Doxycycline Hyclate | 13 | $64 | $5 |
| Tizanidine | 12 | $63 | $5 |
| Carvedilol | 17 | $52 | $3 |
| Azithromycin | 15 | $50 | $3 |
| Doxazosin Mesylate | 12 | $33 | $3 |
| Prednisone | 24 | $32 | $1 |
Year by year
| 2024 | 4,565 | 407 | 2% (87) | 8% | $288,563 |
| 2023 | 2,849 | 332 | 2% (50) | 11% | $262,146 |
| 2022 | 1,750 | 271 | 5% (89) | 10% | $113,204 |
| 2021 | 387 | 127 | 4% (16) | 17% | $22,708 |
| 2020 | 563 | 117 | None | 20% | $44,856 |
| 2019 | 50 | 23 | None | None | $1,558 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 65 drugs
| Jardiance | 28 | $43,344 | $1,548 |
| Eliquis | 31 | $38,662 | $1,247 |
| Ozempic | 26 | $26,908 | $1,035 |
| Lantus Solostar | 20 | $10,174 | $509 |
| Losartan | 120 | $2,120 | $18 |
| Levothyroxine | 103 | $1,944 | $19 |
| Atorvastatin | 176 | $1,861 | $11 |
| Gabapentin | 67 | $1,656 | $25 |
| Pravastatin | 69 | $1,324 | $19 |
| Lisinopril | 125 | $1,277 | $10 |
| Telmisartan-Amlodipine | 11 | $1,213 | $110 |
| Amlodipine Besylate | 147 | $1,106 | $8 |
| Omeprazole | 70 | $1,072 | $15 |
| Albuterol Sulfate Hfa | 38 | $1,007 | $26 |
| Pregabalin | 19 | $973 | $51 |
| Famotidine | 52 | $924 | $18 |
| Metoprolol | 46 | $892 | $19 |
| Glipizide Er | 16 | $875 | $55 |
| Metformin | 63 | $865 | $14 |
| Metformin Hcl Er | 54 | $749 | $14 |
| Diclofenac | 26 | $737 | $28 |
| Tamsulosin | 34 | $730 | $21 |
| Bupropion Xl | 30 | $688 | $23 |
| Allopurinol | 38 | $637 | $17 |
| Benazepril | 15 | $611 | $41 |
| Fluoxetine | 27 | $597 | $22 |
| Rosuvastatin | 49 | $589 | $12 |
| Clopidogrel | 24 | $573 | $24 |
| Metoprolol | 34 | $546 | $16 |
| Oxycodone | 17 | $500 | $29 |
| Pantoprazole | 43 | $479 | $11 |
| Diltiazem 24hr Er (Cd) | 16 | $458 | $29 |
| Oxybutynin Chloride | 12 | $439 | $37 |
| Triamterene-Hydrochlorothiazid | 18 | $437 | $24 |
| Duloxetine | 19 | $412 | $22 |
| Hydrochlorothiazide | 69 | $387 | $6 |
| Montelukast | 16 | $378 | $24 |
| Doxazosin Mesylate | 19 | $337 | $18 |
| Furosemide | 50 | $330 | $7 |
| Valsartan | 12 | $328 | $27 |
| Chlorthalidone | 12 | $326 | $27 |
| Simvastatin | 35 | $316 | $9 |
| Nystatin | 14 | $313 | $22 |
| Sertraline | 35 | $312 | $9 |
| Escitalopram | 21 | $258 | $12 |
| Fluticasone Propionate | 20 | $238 | $12 |
| Glimepiride | 12 | $206 | $17 |
| Hydroxyzine | 16 | $195 | $12 |
| Olanzapine | 11 | $188 | $17 |
| Ketoconazole | 12 | $165 | $14 |
| Triamcinolone Acetonide | 16 | $164 | $10 |
| Alendronate | 20 | $155 | $8 |
| Hydrocodone-Acetaminophen | 15 | $147 | $10 |
| Trazodone | 12 | $144 | $12 |
| Zolpidem | 11 | $142 | $13 |
| Lamotrigine | 12 | $142 | $12 |
| Carvedilol | 13 | $138 | $11 |
| Venlafaxine Hcl Er | 11 | $116 | $11 |
| Citalopram Hbr | 11 | $110 | $10 |
| Fluconazole | 12 | $104 | $9 |
| Lorazepam | 18 | $87 | $5 |
| Atenolol | 16 | $73 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $67 | $6 |
| Azithromycin | 14 | $65 | $5 |
| Ibuprofen | 12 | $62 | $5 |
2022: 49 drugs
| Eliquis | 11 | $17,344 | $1,577 |
| Jardiance | 15 | $12,157 | $810 |
| Lantus Solostar | 13 | $9,548 | $734 |
| Albuterol Sulfate Hfa | 44 | $1,664 | $38 |
| Levothyroxine | 92 | $1,454 | $16 |
| Gabapentin | 56 | $1,169 | $21 |
| Atorvastatin | 69 | $742 | $11 |
| Pravastatin | 36 | $629 | $17 |
| Oxycodone | 17 | $614 | $36 |
| Losartan | 58 | $580 | $10 |
| Amoxicillin-Clavulanate Potass | 34 | $548 | $16 |
| Omeprazole | 28 | $539 | $19 |
| Famotidine | 20 | $522 | $26 |
| Lisinopril | 56 | $504 | $9 |
| Acetaminophen-Codeine | 16 | $468 | $29 |
| Diclofenac | 19 | $450 | $24 |
| Clopidogrel | 18 | $444 | $25 |
| Duloxetine | 15 | $439 | $29 |
| Hydrocodone-Acetaminophen | 45 | $419 | $9 |
| Metoprolol | 23 | $392 | $17 |
| Pantoprazole | 20 | $387 | $19 |
| Prednisone | 29 | $360 | $12 |
| Enulose | 17 | $359 | $21 |
| Amlodipine Besylate | 78 | $353 | $5 |
| Sumatriptan | 11 | $351 | $32 |
| Allopurinol | 13 | $350 | $27 |
| Sertraline | 29 | $324 | $11 |
| Trazodone | 24 | $315 | $13 |
| Bupropion Xl | 16 | $312 | $20 |
| Tamsulosin | 14 | $250 | $18 |
| Fluticasone Propionate | 23 | $237 | $10 |
| Metformin Hcl Er | 26 | $209 | $8 |
| Alendronate | 16 | $205 | $13 |
| Doxycycline Hyclate | 13 | $192 | $15 |
| Metoprolol | 16 | $183 | $11 |
| Hydrochlorothiazide | 35 | $176 | $5 |
| Fluoxetine | 13 | $167 | $13 |
| Furosemide | 26 | $156 | $6 |
| Carvedilol | 11 | $152 | $14 |
| Metformin | 29 | $152 | $5 |
| Lorazepam | 20 | $125 | $6 |
| Lactulose | 16 | $122 | $8 |
| Cephalexin | 12 | $114 | $10 |
| Montelukast | 14 | $111 | $8 |
| Simvastatin | 26 | $101 | $4 |
| Zolpidem | 11 | $95 | $9 |
| Warfarin | 11 | $94 | $9 |
| Azithromycin | 13 | $88 | $7 |
| Sulfamethoxazole-Trimethoprim | 13 | $48 | $4 |
2021: 7 drugs
| Albuterol Sulfate Hfa | 15 | $633 | $42 |
| Levothyroxine | 17 | $310 | $18 |
| Atorvastatin | 21 | $306 | $15 |
| Omeprazole | 13 | $283 | $22 |
| Escitalopram | 13 | $216 | $17 |
| Lisinopril | 15 | $198 | $13 |
| Metformin | 16 | $101 | $6 |
2020: 11 drugs
| Novolog Flexpen | 15 | $10,409 | $694 |
| Xulane | 12 | $1,056 | $88 |
| Albuterol Sulfate Hfa | 14 | $616 | $44 |
| Atorvastatin | 32 | $563 | $18 |
| Levothyroxine | 16 | $462 | $29 |
| Omeprazole | 32 | $453 | $14 |
| Metformin | 27 | $144 | $5 |
| Lisinopril | 17 | $105 | $6 |
| Amlodipine Besylate | 16 | $60 | $4 |
| Prednisone | 11 | $42 | $4 |
| Furosemide | 11 | $40 | $4 |
Money from drug and device companies
$13 in 2019
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Nexplanon | $13 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2019-01-10 | Nexplanon | $13 |
Professional record
- NPI
- 1710472279
- Licence
- MI 5101023959, WA OP61166424Washington DO.OP.61166424: Active
- Trained
- Michigan State University College of Osteopathic Medicine, 2018
- Group
- Permanente Medical Group Inc · Valley Medical Group-Renton
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 276 International Cir Bldg 1, San Jose, CA, 95119
- NPI first listed
- 2018-06-27
- NPI last updated
- 2026-02-04
- NPI record certified
- 2026-02-04
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.